FYI: Meet the UChicago researcher whose math just predicted the federal GLP-1 retreat. (4 days early.)
Dr. David Kim cold-emailed Harvard as a student. He's now a UChicago health economist whose three peer-reviewed papers built the academic case that GLP-1s aren't cost-effective at lifetime use prices. The federal government walked away from Medicare Part D expansion 4 days ago. Kim's framework just got validated in real time.
